Gliclazide: a general free radical scavenger.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-10-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0922-4106(91)90069-TPMID 1800127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Free Radical Activity in Type 2 Diabetes

  1990cited by this paper
• Captopril: a free radical scavenger.

  1989cited by this paper
• Effect of gliclazide on thromboxane B2, parameters of haemostasis, fluorescent IgG and lipid peroxides in non-insulin dependent diabetes mellitus.

  1988cited by this paper
• Increased Diene Conjugates in Diabetic Subjects with Microangiopathy

  1987cited by this paper
• Glutathione and Its Redox System in Diabetic Polymorphonuclear Leukocytes

  1984cited by this paper
• Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.

  1984cited by this paper
• Glutathione and Its Redox System in Diabetic Polymorphonuclear Leukocytes

  1984cited by this paper
• [Effects of gliclazide and glibenclamide on platelet function, fibrinolysis and metabolic control in diabetic patients with retinopathy (author's transl)].

  1982cited by this paper
• Prostaglandin biosynthesis can be triggered by lipid peroxides.

  1979cited by this paper
• Superoxide dismutase: a photochemical augmentation assay.

  1977cited by this paper

• Gliclazide Ameliorates Neuronal Injury by Attenuating Oxidative Stress in D-gal-Induced Senescent Cells and Aging Mice

  2023cites this paper
• Modulating Gliclazide Release and Bioavailability Utilizing Multiparticulate Drug Delivery Systems

  2021cites this paper
• Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications

  2020cites this paper
• Gliclazide: Biopharmaceutics Characteristics to Discuss the Biowaiver of Immediate and Extended Release Tablets

  2020cites this paper
• Evaluation of Antidiabetic and Histopathological Activities of Embelia robusta Seeds Extract against Alloxan-Induced Diabetic Wistar Rats

  2020cites this paper
• Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice.

  2020cites this paper
• New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats.

  2020cites this paper
• Comparison of the Effects of Prophylactic and Therapeutic Administrations on Peripheral Neuropathy in Streptozotocin-Diabetic Rats with Gliclazide or Methylcobalamin

  2018cites this paper
• Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics

  2018cites this paper
• Synergistic action of ursolic acid and metformin in experimental model of insulin resistance and related behavioral alterations

  2018cites this paper
• Sulfonylurea Blockade of KATP Channels Unmasks a Distinct Type of Glucose-Induced Ca2+ Decrease in Pancreatic &bgr;-Cells

  2017cites this paper
• The effects of gliclazide, methylcobalamin, and gliclazide+methylcobalamin combination therapy on diabetic peripheral neuropathy in rats.

  2016cites this paper
• Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.

  2015cites this paper
• Pharmacodynamic Interaction of Garlic with Gliclazide and Ramipril on Myocardial Injury in Diabetic Rats

  2015cites this paper
• Sulfonylureas and meglitinides: insights into physiology and translational clinical utility

  2015cites this paper
• Angiotensin Inhibitors Potentiate the Hypoglycemic and Antioxidant Effects of Gliclazide in Rats

  2015cites this paper
• Effects of sulfonylureas on lipids in type 2 diabetes mellitus: a meta‐analysis of randomized controlled trials

  2015cites this paper
• Pharmacodynamic Interaction of Garlic with Gliclazide and Ramipril on Myocardial Injury in Diabetic Rats

  2015cites this paper
• Effect of gliclazide on cardiovascular risk factors involved in split-dose streptozotocin induced neonatal rat model: a chronic study -

  2012cites this paper
• Role of KATP channels in β‐cell resistance to oxidative stress

  2012cites this paper
• Gliclazide Does Not Fully Prevent 2-Deoxy-D-Ribose-Induced Oxidative Damage Because It Does Not Restore Glutathione Content in a Pancreatic β-Cell Line

  2012cites this paper
• Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats

  2012cites this paper
• Protective effect of gliclazide on diabetic peripheral neuropathy through Drp-1 mediated-oxidative stress and apoptosis.

  2012cites this paper
• Gliclazide Modified Release

  2012cites this paper
• PEG BASED SOLID DISPERSIONS OF GLICLAZIDE: A COMPARATIVE STUDY Research Article

  2012cites this paper
• The advantages of the treatment of the patients with type 2 diabetes mellitus with gliclazide MR

  2012cites this paper
• Treating diabetes today: a matter of selectivity of sulphonylureas

  2012cites this paper
• Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes.

  2011cites this paper
• Cadmium telluride nanocrystals as luminescent sensitizers in flow analysis.

  2011cites this paper
• Gliclazide may have an antiapoptotic effect related to its antioxidant properties in human normal and cancer cells

  2011cites this paper
• Oxidative stress in type 2 diabetes mellitus and methods for its correction

  2011cites this paper
• Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β‐cell dysfunction in streptozotocin‐nicotinamide‐induced diabetic rats

  2010cites this paper
• Suppression of KATP channel activity protects murine pancreatic beta cells against oxidative stress.

  2009cites this paper
• Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet.

  2009cites this paper
• AN APPRAISAL TO THE SPECIAL SULPHONYLUREA: GLICLAZIDE

  2009cites this paper
• Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.

  2009cites this paper
• Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.

  2008cites this paper
• Acute hyperglycemia and oxidative stress: direct cause and effect?

  2008cites this paper
• Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low‐grade inflammation in patients with type 2 diabetes

  2007cites this paper
• Comparisons between the beneficial effects of different sulphonylurea treatments on ischemia-induced retinal neovascularization.

  2007cites this paper
• Gliclazide: pharmacokinetic–pharmacodynamic relationships in rats

  2007cites this paper
• Gliclazide treatment lowers serum ICAM-1 levels in poorly controlled type 2 diabetic patients.

  2006cites this paper
• Effects of gliclazide beyond metabolic control.

  2006cites this paper
• Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation.

  2006cites this paper
• Comparison of the antioxidant and vascular effects of gliclazide and glibenclamide in Type 2 diabetic patients: a randomized crossover study.

  2006cites this paper
• Effect of vitamin E and C supplementation combined with oral antidiabetic therapy on the endothelial dysfunction in the neonatally streptozotocin injected diabetic rat

  2006cites this paper
• Effect of gliclazide modified release on adiponectin, interleukin‐6, and tumor necrosis factor‐α plasma levels in individuals with type 2 diabetes mellitus

  2006cites this paper
• Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.

  2004cites this paper
• Repression of oxidant-induced nuclear factor-kappaB activity mediates placental cytokine responses in gestational diabetes.

  2004cites this paper
• Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes

  2004cites this paper
• The mechanisms of inhibitory actions of gliclazide on neutrophils-endothelial cells adhesion and surface expression of endothelial adhesion molecules mediated by a high glucose concentration.

  2003cites this paper
• Diabetic endothelial dysfunction: effect of free radical scavenging in Type 2 diabetic patients.

  2003cites this paper
• Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

  2003cites this paper
• Gliclazide protects pancreatic β-cells from damage by hydrogen peroxide

  2003cites this paper
• Gliclazide protects pancreatic beta-cells from damage by hydrogen peroxide.

  2003cites this paper
• Gliclazide and Diabetic Angiopathy

  2003cites this paper
• Gliclazide modified release: A critical review of pharmacodynamic, metabolic, and vasoprotective effects.

  2003cites this paper
• Gliclazide improves anti‐oxidant status and nitric oxide‐mediated vasodilation in Type 2 diabetes

  2002cites this paper
• Antioxidant effects of gliclazide, glibenclamide, and metformin in patients with type 2 diabetes mellitus

  2002cites this paper
• Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines.

  2002cites this paper
• Gliclazide decreases vascular smooth muscle cell dysfunction induced by cell-mediated oxidized low-density lipoprotein.

  2001cites this paper
• [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].

  2001cites this paper
• Correction of glycosylated oxyhemoglobin-induced impairment of endothelium-dependent vasodilatation by gliclazide.

  2000cites this paper
• Gliclazide scavenges hydroxyl and superoxide radicals: an electron spin resonance study.

  2000cites this paper
• Highly glycated oxyhaemoglobin impairs nitric oxide relaxations in human mesenteric microvessels

  2000cites this paper
• Prevention of endothelial dysfunction in streptozotocin-induced diabetic rats by gliclazide treatment.

  2000cites this paper
• Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium.

  2000cites this paper
• Effect of gliclazide on monocyte-endothelium interactions in diabetes.

  2000cites this paper
• The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy.

  2000cites this paper
• Free radical scavenging activity of sulfonylureas: a clinical assessment of the effect of gliclazide.

  2000cites this paper
• In vitro and in vivo antioxidant properties of gliclazide.

  2000cites this paper
• Vascular benefits of gliclazide beyond glycemic control.

  2000cites this paper
• PRODUCT MONOGRAPH

  2000cites this paper
• Effects of gliclazide on low-density lipoprotein oxidizability and atherosclerosis in cholesterol-fed rabbits.

  2000cites this paper
• Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin

  1999cites this paper
• Inhibition of tumor necrosis factor-alpha with anti-diabetic agents.

  1999cites this paper
• Antioxidant status in experimental type 2 diabetes mellitus: effects of glibenclamide and glipizide on various rat tissues.

  1999cites this paper
• Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment

  1998cites this paper
• Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits

  1998cites this paper
• Inhibitory effect of troglitazone on diabetic neuropathy in streptozotocin-induced diabetic rats

  1998cites this paper
• Gliclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats.

  1998cites this paper
• Are the reactive oxygen-derived species (ROS) interactive properties of the many therapeutic drugs from various categories pertinent to their beneficial effects?

  1997cites this paper
• Microvascular permeability with sulfonylureas in normal and diabetic hamsters.

  1997cites this paper
• Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL.

  1997cites this paper
• The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro.

  1997cites this paper
• Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study.

  1997cites this paper
• Effect of gliclazide on the functional response to calcium in diabetic rat heart.

  1996cites this paper
• Combined Therapy with Insulin and Sulfonylurea for the Treatment of New-Onset Insulin-Dependent Diabetes Mellitus

  1996cites this paper
• Hemobiological properties of gliclazide.

  1994cites this paper
• The effect of gliclazide on plasma urokinase-related fibrinolysis. The results from an exploratory study

  1994cites this paper
• Chronic gliclazide treatment affects basal and post-ischemic cardiac function in diabetic rats.

  1994cites this paper
• The potential of gliclazide, a sulphonylurea to influence the oxidative processes within the pathogenesis of diabetic vascular disease.

  1994cites this paper
• From Hemobiolo A Review of the B y to Vascular Disease: otential of Gliclazide* to Influence the Pathogenesis of Diabetic Vascular Disease

  1994cites this paper
• Neutrophils may contribute to the morbidity and mortality of claudicants

  1994cites this paper
• From hemobiology to vascular disease: a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease.

  1994cites this paper
• The in vitro free radical scavenging activity of tenidap, a new dual cyclo-oxygenase and 5-1ipoxygenase inhibitor

  1992cites this paper